USPH
NYSE · Health Care
U.S. Physical Therapy Inc
$86.09
+1.25 (+1.47%)
Financial Highlights (FY 2026)
Revenue
758.23M
Net Income
38.43M
Gross Margin
19.2%
Profit Margin
5.1%
Rev Growth
+12.2%
D/E Ratio
0.34
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 19.2% | 19.2% | 53.4% | 53.4% |
| Operating Margin | 11.1% | 10.0% | 12.3% | 13.8% |
| Profit Margin | 5.1% | 4.8% | 12.4% | 11.7% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 758.23M | 675.84M | 680.46M | 584.51M |
| Gross Profit | 145.58M | 129.76M | 363.55M | 312.28M |
| Operating Income | 84.01M | 67.40M | 83.61M | 80.89M |
| Net Income | 38.43M | 30.83M | 84.11M | 68.29M |
| Gross Margin | 19.2% | 19.2% | 53.4% | 53.4% |
| Operating Margin | 11.1% | 10.0% | 12.3% | 13.8% |
| Profit Margin | 5.1% | 4.8% | 12.4% | 11.7% |
| Rev Growth | +12.2% | +12.2% | +22.6% | +15.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 158.92M | 158.92M | 109.70M | 120.61M |
| Total Equity | 466.04M | 466.04M | 934.36M | 966.56M |
| D/E Ratio | 0.34 | 0.34 | 0.12 | 0.12 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 105.77M | 89.56M | 108.87M | 97.49M |
| Free Cash Flow | — | — | 45.81M | 45.13M |